Harvard Bioscience (HBIO) Current Taxes (2010 - 2023)

Harvard Bioscience (HBIO) has reported Current Taxes for 14 consecutive years, with $398000.0 the latest figure, recorded in Q2 2023.

• On a quarterly basis, Current Taxes rose 665.38% year-over-year to $398000.0 in Q2 2023; TTM through Jun 2023 was $398000.0, a 665.38% increase from a year earlier, with the FY2021 full-year figure at $224000.0, down 21.68% from the prior year.
• Current Taxes was $398000.0 for Q2 2023 at Harvard Bioscience, down from $700000.0 in the prior quarter.
• Over five years, Current Taxes peaked at $1.3 million in Q1 2019 and troughed at $52000.0 in Q2 2022.
• A 5-year average of $505250.0 and a median of $471000.0 in 2021 frame the typical range for Current Taxes.
• Across the five-year window, Current Taxes surged 3121.05% in 2019 and plunged 90.44% in 2022, its largest moves.
• Over 5 years, Current Taxes stood at $609000.0 in 2019, then sank by 53.04% to $286000.0 in 2020, then retreated by 21.68% to $224000.0 in 2021, then plunged by 76.79% to $52000.0 in 2022, then jumped by 665.38% to $398000.0 in 2023.
• The last three Current Taxes figures came in at $398000.0 (Q2 2023), $700000.0 (Q1 2023), and $52000.0 (Q2 2022), per Business Quant data.